goralatide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bignon, J; Gora-Tybor, J; Grzybowska-Izydorczyk, O; Liu, JM; Robak, T; Wdzieczak-Bakala, J | 1 |
1 other study(ies) available for goralatide and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Angiogenesis Inducing Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Oligopeptides | 2009 |